Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MetaGuideX Ltd logo — Developing New Early Cancer Diagnostics and Treatments, givi...

MetaGuideX Ltd

Developing New Early Cancer Diagnostics and Treatments, giving Novel Insights into Decisions on Patients.

Founded 2020 United Kingdom Oxford, United Kingdom 3 employees Biotechnology, Health Care

General Information

Company Name MetaGuideX Ltd
Founded Year 2020
Location United Kingdom Oxford, United Kingdom +1
Employees 3
Industries Biotechnology, Health Care
Social

Get notified when MetaGuideX Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MetaGuideX Ltd

MetaGuideX Ltd is a United Kingdom-based startup focused on the development of new early cancer diagnostics and treatments. Their slogan, "Developing New Early Cancer Diagnostics and Treatments, giving Novel Insights into Decisions on Patients," reflects their mission to provide better decisions on patient referrals in primary care, ultimately aiming to save lives and assist pharmaceutical companies in accessing patients earlier. The company offers a low-cost assay capable of detecting multiple early-stage cancers from just one milliliter of blood. This breakthrough technology has the potential to revolutionize cancer diagnosis and treatment decision-making processes. Since its founding in 2020, MetaGuideX Ltd has achieved significant milestones, including successful participation in three accelerator programs. As a result, the company has obtained clinical validation for its assay, positioning them for further growth and development. MetaGuideX Ltd also possesses additional novel intellectual property in its pipeline, targeting a broader range of disease indications and metastatic therapy. Notably, the company has achieved these milestones without relying on dilutive funds, highlighting their strategic approach to financial management. As of now, MetaGuideX Ltd has not disclosed its last investment or the involved investors. However, the company's innovative approach to early cancer diagnostics and treatments, along with its substantial progress in clinical validation, makes it an intriguing prospect for potential investors seeking opportunities in the biotechnology and healthcare industries. With a remarkable focus on addressing critical unmet needs in cancer care, MetaGuideX Ltd stands as a promising player in the healthcare startup landscape, offering compelling potential for both financial returns and societal impact.

Taxonomy: early cancer diagnostics, treatment development, cancer assay, clinical validation, IP development, metastatic therapy, accelerator programmes, pharma access, patient referral, primary care, low-cost diagnostics, blood-based diagnostics, non-dilutive funding, novel insights, startup

No funding data available for MetaGuideX Ltd yet.

Get notified when MetaGuideX Ltd raises funding

MetaGuideX Ltd Alternatives & Competitors

MetaGuideX Ltd vs
Singlera Genomics Incorporated
Singlera Genomics Incorporated United States

Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).

Series B
30 employees
Biotechnology, Health Care
Compare MetaGuideX Ltd vs Singlera Genomics Incorporated
MetaGuideX Ltd vs
PreCyte Inc
PreCyte Inc United States

Envisioning a world free from cancer and neurodegenerative disease

3 employees
Biotechnology, Health Care
MetaGuideX Ltd vs
Glycobond
Glycobond Sweden

The company’s first product is an assay for HCC diagnosis, HepaCheC®

Grant
1 employees
Biotechnology, Health Care

FAQ About MetaGuideX Ltd

Developing New Early Cancer Diagnostics and Treatments, giving Novel Insights into Decisions on Patients.
MetaGuideX Ltd was founded in 2020.
MetaGuideX Ltd is headquartered in Oxford, United Kingdom.
MetaGuideX Ltd operates in the following industries: Biotechnology, Health Care.
MetaGuideX Ltd has approximately 3 employees.
Top alternatives and competitors to MetaGuideX Ltd include Singlera Genomics Incorporated, PreCyte Inc, Glycobond, HAWK Biosystems, Fast MDx Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MetaGuideX Ltd and Singlera Genomics Incorporated are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MetaGuideX Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy